Fudr Powder For Solution For Injection 500Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

FUDR: Powder for solution for injection (500mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

FLOXURIDINE (flox YOOR i deen) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat gastrointestinal cancer, including cancer that has spread to the liver.

In-Depth Information

FUDR 500mg Powder for Injection

NDC: 617030331
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Colorectal Cancer

Sometimes used for but not FDA approved for the following conditions:
Hepatocellular Cancer

Storage Information
Reconstituted product may be stored for up to 14 days if refrigerated (36 to 46 degrees F)
Store unreconstituted product at 59 to 86 degrees F
FUDR 500mg Powder for Injection

Reported Side Effects for FUDR 500mg Powder for Injection

Anemia Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
High Bilirubin Level Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
>10.0%*
Severity: MODERATE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with FUDR

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5